APA (7th ed.) Citation

Chang, L., Oblinger, J. L., Smith, A. E., Ferrer, M., Angus, S. P., Hawley, E., . . . Clapp, D. W. (2021). Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK. PloS one, 16(7), e0252048. https://doi.org/10.1371/journal.pone.0252048

Chicago Style (17th ed.) Citation

Chang, Long-Sheng, et al. "Brigatinib Causes Tumor Shrinkage in Both NF2-deficient Meningioma and Schwannoma Through Inhibition of Multiple Tyrosine Kinases but Not ALK." PloS One 16, no. 7 (2021): e0252048. https://doi.org/10.1371/journal.pone.0252048.

MLA (9th ed.) Citation

Chang, Long-Sheng, et al. "Brigatinib Causes Tumor Shrinkage in Both NF2-deficient Meningioma and Schwannoma Through Inhibition of Multiple Tyrosine Kinases but Not ALK." PloS One, vol. 16, no. 7, 2021, p. e0252048, https://doi.org/10.1371/journal.pone.0252048.